Abigail Shell is a Pharmacist at the Piedmont Atlanta Hospital in Georgia. Leigh Keough and Kothanur Rajanna are Clinical Pharmacy Specialists in the Department of Hematology/Oncology at the Memphis VAMC in Tennessee. Correspondence: Abigail Shell (abigail .shell11@gmail.com)
References
Conclusion
In comparisons of standard- and extended-interval dosing of ZA, there was no difference in the incidence of skeletal-related events in veteran patients with bone metastases from MM or CaP.
Author disclosures The authors report no actual or potential conflicts of interest with regard to this article.
Disclaimer The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review the complete prescribing information for specific drugs or drug combinations—including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.
